Opsumit (Macitentan)

Macitentan, the active ingredient in Opsumit, is an endothelin receptor antagonist presented as a 10 mg tablet for oral use. It treats pulmonary arterial hypertension in adults. GNH USA supplies Opsumit as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals worldwide.

GNH USA supplies Opsumit as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals worldwide.

Opsumit is used in the treatment of pulmonary arterial hypertension, a disease pathway involving elevated ​   ​  ​  ​  ​  ​  ​  ​  ​   ​   ​    ​           ​             ​             ​             ​             ​

- Pulmonary arterial hypertension: Improves exercise capacity and delays disease progression. - WHO functional class II/III PAH: Reduces risk of clinical worsening. - PAH associated with connective‑tissue disease: Provides                                                """"  "  " " "" "  "" "  " " "" "" "  "" " "